In brain malignancies (e.g., glioma), BCAA uptake via L–amino acid transporter-1 (LAT1) is enhanced compared to normal astrocytes19 and BCAT1 activity is augmented in primary gliomas with wild-type isocitrate dehydrogenase (IDHwt). Here, BCAT1 is linked to glioma.